脊椎医療機器と生物製剤の世界市場成長 2024-2030Global Spinal Devices and Biologics Market Growth 2024-2030 世界の脊椎装置と生物製剤の市場規模は、2023年の100万米ドルから2030年には100万米ドルに成長すると予測され、2024年から2030年までの年平均成長率は%と予測されています。 LPインフォメーション株式会社(東... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー世界の脊椎装置と生物製剤の市場規模は、2023年の100万米ドルから2030年には100万米ドルに成長すると予測され、2024年から2030年までの年平均成長率は%と予測されています。LPインフォメーション株式会社(東京都千代田区/代表取締役:劉克振、以下LPI)の最新調査レポート「脊椎治療器と生物製剤の産業予測」は、2023年の脊椎治療器と生物製剤の世界総売上高を過去の売上高から検証し、2024年から2030年までの脊椎治療器と生物製剤の予測売上高を地域別・市場分野別に包括的に分析しています。脊椎医療機器と生物製剤の売上高を地域別、市場分野別、サブセクター別に分類し、世界の脊椎医療機器と生物製剤産業の詳細な分析を百万米ドル単位で提供しています。 本インサイトレポートは、世界の脊椎装置および生物製剤の状況を包括的に分析し、製品区分、企業形成、収益、市場シェア、最新動向、M&A活動に関する主要動向を明らかにします。また本レポートでは、加速する世界の脊椎医療機器および生物製剤市場におけるこれらの企業の独自のポジションをより良く理解するために、脊椎医療機器および生物製剤のポートフォリオと能力、市場参入戦略、市場での地位、地理的な足跡に焦点を当てて、主要グローバル企業の戦略を分析しています。 この調査レポートは、脊椎医療機器と生物製剤の世界的な見通しを形成する主要な市場動向、促進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を細分化して、新たな機会のポケットを浮き彫りにします。何百ものボトムアップの質的・量的市場インプットに基づいた透明性の高い手法により、この調査予測は世界の脊椎装置と生物製剤の現状と将来の軌道について非常にニュアンスのある見解を提供します。 脊椎装置と生物製剤の米国市場は、2023年の100万米ドルから2030年には100万米ドルに増加し、2024年から2030年までの年平均成長率は%と推定される。 脊椎デバイスと生物製剤の中国市場は、2023年の100万米ドルから2030年には100万米ドルに、2024年から2030年までの年平均成長率は%と推定される。 脊椎デバイスと生物製剤のヨーロッパ市場は、2023年の百万米ドルから2030年には百万米ドルに増加し、2024年から2030年までの年平均成長率は%と推定される。 脊椎装置と生物製剤の世界の主要企業は、Nuvasive、Orthofix International、Exactech、Wright Medical Group、Johnson & Johnsonなどである。収益面では、2023年には世界の大手2社がほぼ%のシェアを占めている。 本レポートでは、脊髄デバイスと生物製剤市場の包括的な概要、市場シェア、成長機会を、製品タイプ、用途、主要メーカー、主要地域、国別に紹介します。 タイプ別セグメント 脊椎固定 動作保持 非融合技術 骨折治療 その他 用途別セグメント 病院 外来手術センター クリニック その他 本レポートではまた、市場を地域別に分けています: 南北アメリカ アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、一次専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。 ニューバシブ オルソフィックス・インターナショナル イグザクテック ライト・メディカル・グループ ジョンソン・エンド・ジョンソン ジンマー・バイオメット グローバス・メディカル K2M メドトロニック アルファテック・ホールディングス RTIサージカル 本レポートで扱う主な質問 世界の脊髄デバイスと生物製剤市場の10年見通しは? 世界および地域別で、脊髄デバイスと生物製剤市場の成長を促進する要因は何か? 市場別、地域別に最も急成長する技術は何か? 脊椎デバイスと生物製剤の市場機会は最終市場規模によってどのように異なるのか? 脊髄デバイスと生物製剤のタイプ別、用途別内訳は? 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Spinal Devices and Biologics Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Spinal Devices and Biologics by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Spinal Devices and Biologics by Country/Region, 2019, 2023 & 2030 2.2 Spinal Devices and Biologics Segment by Type 2.2.1 Spinal Fusion & Fixation 2.2.2 Motion Preservation 2.2.3 Non-Fusion Technologies 2.2.4 Fracture Treatment 2.2.5 Others 2.3 Spinal Devices and Biologics Sales by Type 2.3.1 Global Spinal Devices and Biologics Sales Market Share by Type (2019-2024) 2.3.2 Global Spinal Devices and Biologics Revenue and Market Share by Type (2019-2024) 2.3.3 Global Spinal Devices and Biologics Sale Price by Type (2019-2024) 2.4 Spinal Devices and Biologics Segment by Application 2.4.1 Hospitals 2.4.2 Ambulatory Surgical Centers 2.4.3 Clinics 2.4.4 Others 2.5 Spinal Devices and Biologics Sales by Application 2.5.1 Global Spinal Devices and Biologics Sale Market Share by Application (2019-2024) 2.5.2 Global Spinal Devices and Biologics Revenue and Market Share by Application (2019-2024) 2.5.3 Global Spinal Devices and Biologics Sale Price by Application (2019-2024) 3 Global Spinal Devices and Biologics by Company 3.1 Global Spinal Devices and Biologics Breakdown Data by Company 3.1.1 Global Spinal Devices and Biologics Annual Sales by Company (2019-2024) 3.1.2 Global Spinal Devices and Biologics Sales Market Share by Company (2019-2024) 3.2 Global Spinal Devices and Biologics Annual Revenue by Company (2019-2024) 3.2.1 Global Spinal Devices and Biologics Revenue by Company (2019-2024) 3.2.2 Global Spinal Devices and Biologics Revenue Market Share by Company (2019-2024) 3.3 Global Spinal Devices and Biologics Sale Price by Company 3.4 Key Manufacturers Spinal Devices and Biologics Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Spinal Devices and Biologics Product Location Distribution 3.4.2 Players Spinal Devices and Biologics Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Spinal Devices and Biologics by Geographic Region 4.1 World Historic Spinal Devices and Biologics Market Size by Geographic Region (2019-2024) 4.1.1 Global Spinal Devices and Biologics Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Spinal Devices and Biologics Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Spinal Devices and Biologics Market Size by Country/Region (2019-2024) 4.2.1 Global Spinal Devices and Biologics Annual Sales by Country/Region (2019-2024) 4.2.2 Global Spinal Devices and Biologics Annual Revenue by Country/Region (2019-2024) 4.3 Americas Spinal Devices and Biologics Sales Growth 4.4 APAC Spinal Devices and Biologics Sales Growth 4.5 Europe Spinal Devices and Biologics Sales Growth 4.6 Middle East & Africa Spinal Devices and Biologics Sales Growth 5 Americas 5.1 Americas Spinal Devices and Biologics Sales by Country 5.1.1 Americas Spinal Devices and Biologics Sales by Country (2019-2024) 5.1.2 Americas Spinal Devices and Biologics Revenue by Country (2019-2024) 5.2 Americas Spinal Devices and Biologics Sales by Type 5.3 Americas Spinal Devices and Biologics Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Spinal Devices and Biologics Sales by Region 6.1.1 APAC Spinal Devices and Biologics Sales by Region (2019-2024) 6.1.2 APAC Spinal Devices and Biologics Revenue by Region (2019-2024) 6.2 APAC Spinal Devices and Biologics Sales by Type 6.3 APAC Spinal Devices and Biologics Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Spinal Devices and Biologics by Country 7.1.1 Europe Spinal Devices and Biologics Sales by Country (2019-2024) 7.1.2 Europe Spinal Devices and Biologics Revenue by Country (2019-2024) 7.2 Europe Spinal Devices and Biologics Sales by Type 7.3 Europe Spinal Devices and Biologics Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Spinal Devices and Biologics by Country 8.1.1 Middle East & Africa Spinal Devices and Biologics Sales by Country (2019-2024) 8.1.2 Middle East & Africa Spinal Devices and Biologics Revenue by Country (2019-2024) 8.2 Middle East & Africa Spinal Devices and Biologics Sales by Type 8.3 Middle East & Africa Spinal Devices and Biologics Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Spinal Devices and Biologics 10.3 Manufacturing Process Analysis of Spinal Devices and Biologics 10.4 Industry Chain Structure of Spinal Devices and Biologics 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Spinal Devices and Biologics Distributors 11.3 Spinal Devices and Biologics Customer 12 World Forecast Review for Spinal Devices and Biologics by Geographic Region 12.1 Global Spinal Devices and Biologics Market Size Forecast by Region 12.1.1 Global Spinal Devices and Biologics Forecast by Region (2025-2030) 12.1.2 Global Spinal Devices and Biologics Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Spinal Devices and Biologics Forecast by Type 12.7 Global Spinal Devices and Biologics Forecast by Application 13 Key Players Analysis 13.1 Nuvasive 13.1.1 Nuvasive Company Information 13.1.2 Nuvasive Spinal Devices and Biologics Product Portfolios and Specifications 13.1.3 Nuvasive Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 Nuvasive Main Business Overview 13.1.5 Nuvasive Latest Developments 13.2 Orthofix International 13.2.1 Orthofix International Company Information 13.2.2 Orthofix International Spinal Devices and Biologics Product Portfolios and Specifications 13.2.3 Orthofix International Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 Orthofix International Main Business Overview 13.2.5 Orthofix International Latest Developments 13.3 Exactech 13.3.1 Exactech Company Information 13.3.2 Exactech Spinal Devices and Biologics Product Portfolios and Specifications 13.3.3 Exactech Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 Exactech Main Business Overview 13.3.5 Exactech Latest Developments 13.4 Wright Medical Group 13.4.1 Wright Medical Group Company Information 13.4.2 Wright Medical Group Spinal Devices and Biologics Product Portfolios and Specifications 13.4.3 Wright Medical Group Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 Wright Medical Group Main Business Overview 13.4.5 Wright Medical Group Latest Developments 13.5 Johnson & Johnson 13.5.1 Johnson & Johnson Company Information 13.5.2 Johnson & Johnson Spinal Devices and Biologics Product Portfolios and Specifications 13.5.3 Johnson & Johnson Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 Johnson & Johnson Main Business Overview 13.5.5 Johnson & Johnson Latest Developments 13.6 Zimmer Biomet 13.6.1 Zimmer Biomet Company Information 13.6.2 Zimmer Biomet Spinal Devices and Biologics Product Portfolios and Specifications 13.6.3 Zimmer Biomet Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 Zimmer Biomet Main Business Overview 13.6.5 Zimmer Biomet Latest Developments 13.7 Globus Medical 13.7.1 Globus Medical Company Information 13.7.2 Globus Medical Spinal Devices and Biologics Product Portfolios and Specifications 13.7.3 Globus Medical Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 Globus Medical Main Business Overview 13.7.5 Globus Medical Latest Developments 13.8 K2M 13.8.1 K2M Company Information 13.8.2 K2M Spinal Devices and Biologics Product Portfolios and Specifications 13.8.3 K2M Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 K2M Main Business Overview 13.8.5 K2M Latest Developments 13.9 Medtronic 13.9.1 Medtronic Company Information 13.9.2 Medtronic Spinal Devices and Biologics Product Portfolios and Specifications 13.9.3 Medtronic Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024) 13.9.4 Medtronic Main Business Overview 13.9.5 Medtronic Latest Developments 13.10 Alphatec Holdings 13.10.1 Alphatec Holdings Company Information 13.10.2 Alphatec Holdings Spinal Devices and Biologics Product Portfolios and Specifications 13.10.3 Alphatec Holdings Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024) 13.10.4 Alphatec Holdings Main Business Overview 13.10.5 Alphatec Holdings Latest Developments 13.11 RTI Surgical 13.11.1 RTI Surgical Company Information 13.11.2 RTI Surgical Spinal Devices and Biologics Product Portfolios and Specifications 13.11.3 RTI Surgical Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024) 13.11.4 RTI Surgical Main Business Overview 13.11.5 RTI Surgical Latest Developments 14 Research Findings and Conclusion
SummaryThe global Spinal Devices and Biologics market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Spinal Devices and Biologics Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Spinal Devices and Biologics by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Spinal Devices and Biologics by Country/Region, 2019, 2023 & 2030 2.2 Spinal Devices and Biologics Segment by Type 2.2.1 Spinal Fusion & Fixation 2.2.2 Motion Preservation 2.2.3 Non-Fusion Technologies 2.2.4 Fracture Treatment 2.2.5 Others 2.3 Spinal Devices and Biologics Sales by Type 2.3.1 Global Spinal Devices and Biologics Sales Market Share by Type (2019-2024) 2.3.2 Global Spinal Devices and Biologics Revenue and Market Share by Type (2019-2024) 2.3.3 Global Spinal Devices and Biologics Sale Price by Type (2019-2024) 2.4 Spinal Devices and Biologics Segment by Application 2.4.1 Hospitals 2.4.2 Ambulatory Surgical Centers 2.4.3 Clinics 2.4.4 Others 2.5 Spinal Devices and Biologics Sales by Application 2.5.1 Global Spinal Devices and Biologics Sale Market Share by Application (2019-2024) 2.5.2 Global Spinal Devices and Biologics Revenue and Market Share by Application (2019-2024) 2.5.3 Global Spinal Devices and Biologics Sale Price by Application (2019-2024) 3 Global Spinal Devices and Biologics by Company 3.1 Global Spinal Devices and Biologics Breakdown Data by Company 3.1.1 Global Spinal Devices and Biologics Annual Sales by Company (2019-2024) 3.1.2 Global Spinal Devices and Biologics Sales Market Share by Company (2019-2024) 3.2 Global Spinal Devices and Biologics Annual Revenue by Company (2019-2024) 3.2.1 Global Spinal Devices and Biologics Revenue by Company (2019-2024) 3.2.2 Global Spinal Devices and Biologics Revenue Market Share by Company (2019-2024) 3.3 Global Spinal Devices and Biologics Sale Price by Company 3.4 Key Manufacturers Spinal Devices and Biologics Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Spinal Devices and Biologics Product Location Distribution 3.4.2 Players Spinal Devices and Biologics Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Spinal Devices and Biologics by Geographic Region 4.1 World Historic Spinal Devices and Biologics Market Size by Geographic Region (2019-2024) 4.1.1 Global Spinal Devices and Biologics Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Spinal Devices and Biologics Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Spinal Devices and Biologics Market Size by Country/Region (2019-2024) 4.2.1 Global Spinal Devices and Biologics Annual Sales by Country/Region (2019-2024) 4.2.2 Global Spinal Devices and Biologics Annual Revenue by Country/Region (2019-2024) 4.3 Americas Spinal Devices and Biologics Sales Growth 4.4 APAC Spinal Devices and Biologics Sales Growth 4.5 Europe Spinal Devices and Biologics Sales Growth 4.6 Middle East & Africa Spinal Devices and Biologics Sales Growth 5 Americas 5.1 Americas Spinal Devices and Biologics Sales by Country 5.1.1 Americas Spinal Devices and Biologics Sales by Country (2019-2024) 5.1.2 Americas Spinal Devices and Biologics Revenue by Country (2019-2024) 5.2 Americas Spinal Devices and Biologics Sales by Type 5.3 Americas Spinal Devices and Biologics Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Spinal Devices and Biologics Sales by Region 6.1.1 APAC Spinal Devices and Biologics Sales by Region (2019-2024) 6.1.2 APAC Spinal Devices and Biologics Revenue by Region (2019-2024) 6.2 APAC Spinal Devices and Biologics Sales by Type 6.3 APAC Spinal Devices and Biologics Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Spinal Devices and Biologics by Country 7.1.1 Europe Spinal Devices and Biologics Sales by Country (2019-2024) 7.1.2 Europe Spinal Devices and Biologics Revenue by Country (2019-2024) 7.2 Europe Spinal Devices and Biologics Sales by Type 7.3 Europe Spinal Devices and Biologics Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Spinal Devices and Biologics by Country 8.1.1 Middle East & Africa Spinal Devices and Biologics Sales by Country (2019-2024) 8.1.2 Middle East & Africa Spinal Devices and Biologics Revenue by Country (2019-2024) 8.2 Middle East & Africa Spinal Devices and Biologics Sales by Type 8.3 Middle East & Africa Spinal Devices and Biologics Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Spinal Devices and Biologics 10.3 Manufacturing Process Analysis of Spinal Devices and Biologics 10.4 Industry Chain Structure of Spinal Devices and Biologics 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Spinal Devices and Biologics Distributors 11.3 Spinal Devices and Biologics Customer 12 World Forecast Review for Spinal Devices and Biologics by Geographic Region 12.1 Global Spinal Devices and Biologics Market Size Forecast by Region 12.1.1 Global Spinal Devices and Biologics Forecast by Region (2025-2030) 12.1.2 Global Spinal Devices and Biologics Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Spinal Devices and Biologics Forecast by Type 12.7 Global Spinal Devices and Biologics Forecast by Application 13 Key Players Analysis 13.1 Nuvasive 13.1.1 Nuvasive Company Information 13.1.2 Nuvasive Spinal Devices and Biologics Product Portfolios and Specifications 13.1.3 Nuvasive Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 Nuvasive Main Business Overview 13.1.5 Nuvasive Latest Developments 13.2 Orthofix International 13.2.1 Orthofix International Company Information 13.2.2 Orthofix International Spinal Devices and Biologics Product Portfolios and Specifications 13.2.3 Orthofix International Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 Orthofix International Main Business Overview 13.2.5 Orthofix International Latest Developments 13.3 Exactech 13.3.1 Exactech Company Information 13.3.2 Exactech Spinal Devices and Biologics Product Portfolios and Specifications 13.3.3 Exactech Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 Exactech Main Business Overview 13.3.5 Exactech Latest Developments 13.4 Wright Medical Group 13.4.1 Wright Medical Group Company Information 13.4.2 Wright Medical Group Spinal Devices and Biologics Product Portfolios and Specifications 13.4.3 Wright Medical Group Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 Wright Medical Group Main Business Overview 13.4.5 Wright Medical Group Latest Developments 13.5 Johnson & Johnson 13.5.1 Johnson & Johnson Company Information 13.5.2 Johnson & Johnson Spinal Devices and Biologics Product Portfolios and Specifications 13.5.3 Johnson & Johnson Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 Johnson & Johnson Main Business Overview 13.5.5 Johnson & Johnson Latest Developments 13.6 Zimmer Biomet 13.6.1 Zimmer Biomet Company Information 13.6.2 Zimmer Biomet Spinal Devices and Biologics Product Portfolios and Specifications 13.6.3 Zimmer Biomet Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 Zimmer Biomet Main Business Overview 13.6.5 Zimmer Biomet Latest Developments 13.7 Globus Medical 13.7.1 Globus Medical Company Information 13.7.2 Globus Medical Spinal Devices and Biologics Product Portfolios and Specifications 13.7.3 Globus Medical Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 Globus Medical Main Business Overview 13.7.5 Globus Medical Latest Developments 13.8 K2M 13.8.1 K2M Company Information 13.8.2 K2M Spinal Devices and Biologics Product Portfolios and Specifications 13.8.3 K2M Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 K2M Main Business Overview 13.8.5 K2M Latest Developments 13.9 Medtronic 13.9.1 Medtronic Company Information 13.9.2 Medtronic Spinal Devices and Biologics Product Portfolios and Specifications 13.9.3 Medtronic Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024) 13.9.4 Medtronic Main Business Overview 13.9.5 Medtronic Latest Developments 13.10 Alphatec Holdings 13.10.1 Alphatec Holdings Company Information 13.10.2 Alphatec Holdings Spinal Devices and Biologics Product Portfolios and Specifications 13.10.3 Alphatec Holdings Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024) 13.10.4 Alphatec Holdings Main Business Overview 13.10.5 Alphatec Holdings Latest Developments 13.11 RTI Surgical 13.11.1 RTI Surgical Company Information 13.11.2 RTI Surgical Spinal Devices and Biologics Product Portfolios and Specifications 13.11.3 RTI Surgical Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024) 13.11.4 RTI Surgical Main Business Overview 13.11.5 RTI Surgical Latest Developments 14 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
LP Information社の医療分野での最新刊レポート
本レポートと同じKEY WORD(devices)の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|